Founded in 2018, Washington-DC–based Sorcero offers an Agentic AI platform—comprising Sorcero Medical, SciComms, Safety and Medtech—that is specifically trained on life-science data and built to meet stringent regulatory and privacy requirements. The system unifies hundreds of global data sources to create a 360° view of more than 40 million healthcare professionals and 100 million scientists, enabling customers to analyze 263 million publications and 1.3 billion citations for real-time insights. One-third of the top 30 global pharmaceutical firms use Sorcero, achieving up to 92 % productivity gains in evidence generation, 72 % faster insight discovery, and publication timelines shortened by two to five months. The platform delivers 96.1 % clinical inclusion accuracy—exceeding FDA regulatory thresholds and PhD-level human performance. Sorcero’s offerings support medical affairs, safety, scientific communications, and medical devices, and are available directly and through channels such as the Google Cloud Marketplace and NIH STRIDES. Recent strategic moves include the acquisition of Axiom Health to bolster its med-device capabilities and partnerships with Google Cloud, Springer Nature, ServiceNow, USDM Life Sciences, and Snowflake. With a cumulative $59 million raised, the company plans to scale globally and further develop its insight-driven engagement model for precision medicine.

Total raised

$56M

Funding rounds

3

Latest round

Series B

Latest activity

Nov 2025